{"id":1825,"date":"2020-01-03T12:16:38","date_gmt":"2020-01-03T10:16:38","guid":{"rendered":"http:\/\/www.eiqsh.eu\/?p=1825"},"modified":"2020-03-18T07:48:36","modified_gmt":"2020-03-18T05:48:36","slug":"healthcare-acquired-infections","status":"publish","type":"post","link":"https:\/\/eiqsh.eu\/en\/healthcare-acquired-infections\/","title":{"rendered":"International practice and guidelines for Healthcare Acquired Infections- Antibiotics Controlled Use- Antibiotics Stewardship Principles"},"content":{"rendered":"

Duration<\/strong>:\u00a02 days-\u00a015 Hours<\/strong><\/p>\n

Language: English & Greek<\/strong><\/p>\n

Certificate of Attendance<\/strong><\/p>\n

Level: General<\/strong><\/p>\n

<\/p>\n

Healthcare Acquired Infections is one of the high priorities of the Healthcare Systems in Europe among the main public health issues which are addressed in the latest report of OECD\/EU (2018), Health at a Glance: Europe 2018: State of Health in the EU Cycle.<\/p>\n

The European Centre for Disease Control estimates that 3.8 million people acquire a healthcare-associated infection each year in acute care hospitals in EU countries and Norway and Iceland (Suetens et al., 2018), and an estimated 90.000 people in the EU die each year due to the six most common infections in health care settings (Cassini, 2016). At least 20% of healthcare-associated infections are considered to be avoidable through better infection prevention and control (Harbath, 2003).<\/p>\n

On average across EU countries (weighted), 5.5% of patients acquired an infection during their hospital stay in 2016-2017. The observed percentage was lowest in Lithuania, Bulgaria, Germany, Latvia, the Netherlands and Romania (less than 4%), and highest in Greece, Portugal, Italy, Finland and Cyprus (more than 8%).<\/p>\n

Compounding the impact of healthcare-associated infections are infections due to antimicrobial resistant bacteria, which can lead to complications, longer hospital stays, or death. A single resistant infection has been estimated to cost about 8.500\u20ac to 34.000\u20ac more than a non-resistant infection, due to additional hospital days and additional treatment costs (OECD, 2017). Inappropriate use of antibiotics contribute to antimicrobial-resistant bacteria in hospitals and in the community.<\/p>\n

Healthcare-associated infections can be prevented by implementing a series of measures, as set out in the Council of the European Union\u2019s Recommendation on Patient Safety, including the Prevention and Control of Healthcare-Associated Infections (2009\/C 151\/01). At the hospital level, key components of effective infection prevention and control strategies include:<\/p>\n